Motivational Interviewing to Prevent Suicide in High Risk Veterans
NCT ID: NCT01544127
Last Updated: 2022-02-25
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
132 participants
INTERVENTIONAL
2012-07-30
2017-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
NCT05256940
Suicide Risk Interventions
NCT05931289
Brief Interventions for Short-Term Suicide Risk Reduction in Military Populations
NCT02042131
A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans- Study 1
NCT01334541
High Risk Suicidal Behavior in Veterans
NCT02462694
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MI-SI+TAU
Motivational Interviewing to Address Suicidal Ideation
MI-SI+TAU
MI-SI focuses on exploring and resolving ambivalence about living. It consists of 1 or 2 in-person MI-SI sessions (50 mins.) on an inpatient unit, plus a telephone follow-up MI-SI session (30-50 mins)
MI-SI-R+TAU
Motivational Interviewing to Address Suicidal Ideation Revised
MI-SI-R+TAU
MI-SI-R focuses on resolving ambivalence about living. It consists of 1 or 2 in-person MI-SI sessions (50 mins.) on an inpatient unit, plus a telephone follow-up MI-SI session (30-50 mins)
TAU Alone
Treatment as usual
TAU Alone
Inpatient treatment includes medication management, case management, meals and a bed, milieu therapy consisting of creative and social activities, and a safety plan. Some families of veterans also received education to create a supportive home environment. As part of Veterans Health Administration (VHA) suicide prevention policy, the care of suicidal patients is also overseen by a local Suicide Prevention Coordinator and case managers.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MI-SI+TAU
MI-SI focuses on exploring and resolving ambivalence about living. It consists of 1 or 2 in-person MI-SI sessions (50 mins.) on an inpatient unit, plus a telephone follow-up MI-SI session (30-50 mins)
MI-SI-R+TAU
MI-SI-R focuses on resolving ambivalence about living. It consists of 1 or 2 in-person MI-SI sessions (50 mins.) on an inpatient unit, plus a telephone follow-up MI-SI session (30-50 mins)
TAU Alone
Inpatient treatment includes medication management, case management, meals and a bed, milieu therapy consisting of creative and social activities, and a safety plan. Some families of veterans also received education to create a supportive home environment. As part of Veterans Health Administration (VHA) suicide prevention policy, the care of suicidal patients is also overseen by a local Suicide Prevention Coordinator and case managers.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to psychiatric inpatient unit,
* age 18 and over,
* English speaking,
* able to understand the study and provide informed consent,
* clinically cleared to participate by unit staff,
* receive health care from a VHA facility in upstate New York
* at increased risk for suicide (Scale for Suicidal Ideation \[SSI\] \> 2)
Exclusion Criteria
* current mania,
* dementia,
* prisoner status,
* being inaccessible
* being discharged from the unit less than 48 hours after being identified by study staff
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter C. Britton, PhD MS
Role: PRINCIPAL_INVESTIGATOR
Syracuse VA Medical Center, Syracuse, NY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Britton PC, Conner KR, Chapman BP, Maisto SA. Motivational Interviewing to Address Suicidal Ideation: A Randomized Controlled Trial in Veterans. Suicide Life Threat Behav. 2020 Feb;50(1):233-248. doi: 10.1111/sltb.12581. Epub 2019 Aug 8.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IK2CX00064
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
MHBA-20-11S
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.